IRCofCA/NovaRx Lucanix NSCLC Vaccine

IRCC is actively working with NovaRx to enroll patients in a research study of Lucanix, an investigational lung cancer vaccine. This vaccine is currently in Phase III trials. You can reach them at (877) 680-IRCC (4722) and they can answer most if not all of your questions about NSCLC and if you or your loved one will qualify. Hope this helps.

[glo306]

Stop advetising for IRCC.  You son't mention the $1500/month fee for a medication that the maker provides for free.  You should tell the enitre truth - Lucanix is a great option for those with lung cancer and is avaialbe via the clinical trial and possibly compassionatet use for some.

Shame on you.